Erasca, Inc. Earnings Per Share (Basic)
Erasca, Inc. (ERAS) reported Earnings Per Share (Basic) of -$0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Erasca, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.14.
- Erasca, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.60.
- Erasca, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.10.
- Erasca, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.11.
- Erasca, Inc. earnings per share, basic for fiscal 2025 was -$0.44.
- Erasca, Inc. earnings per share, basic for fiscal 2024 was -$0.69.
- Erasca, Inc. earnings per share, basic for fiscal 2023 was -$0.83.
- Erasca, Inc. earnings per share, basic for fiscal 2022 was -$1.99.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.14 10-Q · filed 2026-08-11 | -$0.74 10-Q · filed 2026-08-11 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.60 10-Q · filed 2026-05-11 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.44 10-K · filed 2026-03-12 |
| 2025-09-30 | -$0.11 10-Q · filed 2025-11-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.34 10-Q · filed 2025-11-12 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.12 10-Q · filed 2026-08-11 | -$0.23 10-Q · filed 2026-08-11 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.11 10-Q · filed 2026-05-11 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2024-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$0.69 10-K · filed 2026-03-12 |
| 2024-09-30 | -$0.11 10-Q · filed 2025-11-12 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.60 10-Q · filed 2025-11-12 | -$0.79 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.29 10-Q · filed 2025-08-12 | -$0.53 10-Q · filed 2025-08-12 | -$0.74 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.94 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-03-31 | -$0.23 10-Q · filed 2025-05-13 | -$0.43 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.84 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2023-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$0.40 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$0.61 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$0.83 10-K · filed 2025-03-20 |
| 2023-09-30 | -$0.20 10-Q · filed 2024-11-12 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.64 10-Q · filed 2024-11-12 | -$1.60 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.21 10-Q · filed 2024-08-12 | -$0.43 10-Q · filed 2024-08-12 | -$1.41 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-03-31 | -$0.22 10-Q · filed 2024-05-08 | -$1.22 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.85 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2022-12-31 | -$1.06 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.68 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.99 10-K · filed 2024-03-27 |
| 2022-09-30 | -$0.29 10-Q · filed 2023-11-09 | -$0.59 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.90 10-Q · filed 2023-11-09 | -$1.15 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.30 10-Q · filed 2023-08-10 | -$0.60 10-Q · filed 2023-08-10 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.30 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.31 10-Q · filed 2023-05-15 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.56 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.30 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.85 10-K · filed 2023-03-23 |
| 2021-09-30 | -$0.46 10-Q · filed 2022-11-09 | -$1.21 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.90 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$1.20 10-Q · filed 2022-08-11 | -$2.02 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |